M early psychological interventions are no better at reducing posttraumatic stress disorder symptoms than no intervention at all and might even increase symptoms in some individuals, a review of 11 randomized controlled studies shows. “There was no evidence that a multiple session intervention aimed at everyone following a traumatic event was effective. There was a trend that just failed to rea...

Therapeutic use, overuse, abuse, and diversion of controlled substances in managing chronic non-cancer pain continue to be an issue for physicians and patients. The challenge is to eliminate or significantly curtail abuse of controlled prescription drugs while still assuring the proper treatment of those patients. Some physicians are apprehensive regarding the use of chronic opioid therapy in c...

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 added prescription drug coverage to Medicare beginning in January 2006. The prescription drug coverage is voluntary, although beneficiaries face a significant penalty for delaying enrollment. The drug coverage is provided through private drug plans; beneficiaries have a choice of staying in the original Medicare program ...

Ultram (tramadol HCL) was approved by the Food and Drug Administration in 1994 as a non-scheduled drug under the Controlled Substance Act. The non-scheduled status was contingent on the development and implementation of a comprehensive post-marketing surveillance program by an Independent Steering Committee external to Ortho-McNeil Pharmaceutical charged with monitoring abuse and recommending s...